China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Immunochemotherapy for Recurrent Esophageal Carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135153
Registration Time: 2026/10/26
Type: Observational study
Primary Sponsor: JIANGSU CANCER HOSPITAL
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=330528
Published by HT Digital Content Services with permission from Health Daily Digest....